Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Graft vs Host Disease"" wg kryterium: Temat


Tytuł:
Comparison of tacrolimus vs. cyclosporine in pediatric hematopoietic stem cell transplantation for thalassemia.
Autorzy:
Zhumatayev S; Department of Pediatric Hematology and Oncology, Goztepe Medical Park Hospital, Istanbul, Turkey.
Yalcin K; Department of Pediatric Hematology and Oncology, Bahcesehir University, Goztepe Medical Park Hospital, Istanbul, Turkey.; Department of Medical Biotechnology, Institute of Health Science, Acibadem University, Istanbul, Turkey.
Celen SS; Department of Pediatric Hematology and Oncology, Bahcesehir University, Goztepe Medical Park Hospital, Istanbul, Turkey.
Karaman I; Bahcesehir University School of Medicine, Istanbul, Turkey.
Daloglu H; Department of Pediatric Hematology and Oncology, Antalya Medical Park Hospital, Antalya, Turkey.
Ozturkmen S; Department of Pediatric Hematology and Oncology, Antalya Medical Park Hospital, Antalya, Turkey.
Uygun V; Department of Pediatric Hematology and Oncology, Istinye University, Goztepe Medical Park Hospital, Istanbul, Turkey.
Karasu G; Department of Pediatric Hematology and Oncology, Goztepe Medical Park Hospital, Istanbul, Turkey.; Department of Pediatric Hematology and Oncology, Antalya Medical Park Hospital, Antalya, Turkey.
Yesilipek A; Department of Pediatric Hematology and Oncology, Goztepe Medical Park Hospital, Istanbul, Turkey.; Department of Pediatric Hematology and Oncology, Antalya Medical Park Hospital, Antalya, Turkey.
Pokaż więcej
Źródło:
Pediatric transplantation [Pediatr Transplant] 2024 Feb; Vol. 28 (1), pp. e14688.
Typ publikacji:
Journal Article
MeSH Terms:
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Graft vs Host Disease*/epidemiology
Hematopoietic Stem Cell Transplantation*/adverse effects
Thalassemia*
Humans ; Child ; Cyclosporine/therapeutic use ; Tacrolimus/therapeutic use ; Immunosuppressive Agents/therapeutic use ; Retrospective Studies ; Calcineurin Inhibitors/therapeutic use ; Receptors, Antigen, T-Cell
Czasopismo naukowe
Tytuł:
Adolescent and Young Adult Patients with Vaginal Graft-vs-Host Disease and Hematocolpos Managed with Vaginal Stents: A Case Series.
Autorzy:
Hollond CS; Pomona College, Claremont, California.
Ganti A; Department of OB/GYN, Division of Pediatric and Adolescent Gynecology, Stanford University School of Medicine, Stanford, California.
Streich-Tilles T; Department of Surgery, Division of Pediatric and Adolescent Gynecology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Debiec K; Department of Obstetrics and Gynecology, Division of Pediatric and Adolescent Gynecology, University of Washington and Seattle Children's, Seattle, Washington.
Galloway A; Grinnell College, Grinnell, Iowa.
Inneh O; Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, Washington.
Cizek S; Department of OB/GYN, Division of Pediatric and Adolescent Gynecology, Stanford University School of Medicine, Stanford, California. Electronic address: .
Pokaż więcej
Źródło:
Journal of pediatric and adolescent gynecology [J Pediatr Adolesc Gynecol] 2024 Feb; Vol. 37 (1), pp. 78-86. Date of Electronic Publication: 2023 Oct 04.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Hematocolpos*/complications
Hematopoietic Stem Cell Transplantation*/adverse effects
Graft vs Host Disease*/complications
Graft vs Host Disease*/therapy
Humans ; Adolescent ; Young Adult ; Female ; Vagina/surgery ; Constriction, Pathologic/etiology ; Constriction, Pathologic/therapy ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Exploring strategies to optimise outcomes in hepatitis-associated aplastic anaemia patients following haematopoietic stem cell transplantation.
Autorzy:
Li J; Haematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Liu Y; Haematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Wang J; Haematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Wang Y; Haematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.; Department of Haematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
Pang A; Haematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Yang D; Haematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Chen X; Haematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Zhang R; Haematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Wei J; Haematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Ma Q; Haematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Zhai W; Haematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
He Y; Haematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Jiang E; Haematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Han M; Haematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Feng S; Haematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China. doctor_.; Tianjin Institutes of Health Science, Tianjin, 301600, China. doctor_.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 02; Vol. 14 (1), pp. 5178. Date of Electronic Publication: 2024 Mar 02.
Typ publikacji:
Journal Article
MeSH Terms:
Anemia, Aplastic*/complications
Anemia, Aplastic*/therapy
Hematopoietic Stem Cell Transplantation*/adverse effects
Graft vs Host Disease*/etiology
Hepatitis*/complications
Hepatitis A*
Humans ; Male ; Child ; Adolescent ; Young Adult ; Adult ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Autophagy differentially regulates tissue tolerance of distinct target organs in graft-versus-host disease models.
Autorzy:
Oravecz-Wilson K; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, Michigan, USA.
Lauder E; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, Michigan, USA.; Dan L. Duncan Comprehensive Cancer Center and.
Taylor A; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, Michigan, USA.
Maneix L; Dan L. Duncan Comprehensive Cancer Center and.
Van Nostrand JL; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.
Sun Y; Dan L. Duncan Comprehensive Cancer Center and.
Li L; Dan L. Duncan Comprehensive Cancer Center and.
Zhao D; Dan L. Duncan Comprehensive Cancer Center and.
Liu C; Department of Pathology, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Reddy P; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, Michigan, USA.; Dan L. Duncan Comprehensive Cancer Center and.
Pokaż więcej
Źródło:
The Journal of clinical investigation [J Clin Invest] 2024 Mar 01; Vol. 134 (5). Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Graft vs Host Disease*/genetics
Graft vs Host Disease*/pathology
Hematopoietic Stem Cell Transplantation*
Animals ; Mice ; Intestines/pathology ; T-Lymphocytes/pathology ; Epithelial Cells/pathology
Czasopismo naukowe
Tytuł:
Mitochondrial-targeted curcumin inhibits T-cell activation via Nrf2 and inhibits graft-versus-host-disease in a mouse model.
Autorzy:
Patwardhan RS; Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, India.
Gohil D; Homi Bhabha National Institute, Training School Complex, Anushaktinagar, Mumbai, India.; Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
Singh B; Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, India.
Kumar BK; Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, India.
Purohit V; Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, India.
Thoh M; Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, India.
Checker R; Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, India.; Homi Bhabha National Institute, Training School Complex, Anushaktinagar, Mumbai, India.
Gardi N; Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
Gota V; Homi Bhabha National Institute, Training School Complex, Anushaktinagar, Mumbai, India.; Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
Kutala VK; Department of Biochemistry, Nizam's Institute of Medical Sciences (NIMS), Hyderabad, India.
Patwardhan S; Homi Bhabha National Institute, Training School Complex, Anushaktinagar, Mumbai, India.; Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
Sharma D; Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, India.; Homi Bhabha National Institute, Training School Complex, Anushaktinagar, Mumbai, India.
Sandur SK; Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, India.; Homi Bhabha National Institute, Training School Complex, Anushaktinagar, Mumbai, India.
Pokaż więcej
Źródło:
Phytotherapy research : PTR [Phytother Res] 2024 Mar; Vol. 38 (3), pp. 1555-1573. Date of Electronic Publication: 2024 Jan 28.
Typ publikacji:
Journal Article
MeSH Terms:
Curcumin*/*analogs & derivatives
Curcumin*/pharmacology
Graft vs Host Disease*/metabolism
Graft vs Host Disease*/pathology
Animals ; Mice ; NF-E2-Related Factor 2/metabolism ; T-Lymphocytes ; Disease Models, Animal ; Sulfhydryl Compounds/metabolism ; Sulfhydryl Compounds/pharmacology
Czasopismo naukowe
Tytuł:
HLA-haploidentical T-cell receptor αβT/B-cell-depleted stem cell transplantation for Fanconi anemia.
Autorzy:
Iguchi A; Children's Cancer Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan. .
Uchiyama T; Children's Cancer Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.; Gene and Cell Therapy Promotion Center, National Center for Child Health and Development, Tokyo, Japan.
Fujimori K; Children's Cancer Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
Gocho Y; Children's Cancer Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
Sakaguchi H; Children's Cancer Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
Deguchi T; Children's Cancer Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
Tomizawa D; Children's Cancer Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
Imadome KI; Department of Advanced Medicine for Infections, National Center for Child Health and Development, Tokyo, Japan.
Onodera M; Gene and Cell Therapy Promotion Center, National Center for Child Health and Development, Tokyo, Japan.
Matsumoto K; Children's Cancer Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
Pokaż więcej
Źródło:
International journal of hematology [Int J Hematol] 2024 Mar; Vol. 119 (3), pp. 334-337. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Fanconi Anemia*/therapy
Fanconi Anemia*/complications
Hematopoietic Stem Cell Transplantation*/adverse effects
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Graft vs Host Disease*/drug therapy
Male ; Humans ; Child ; Cyclophosphamide ; Receptors, Antigen, T-Cell ; Transplantation Conditioning/adverse effects
Czasopismo naukowe
Tytuł:
How does ocular graft-versus-host disease fit under the dry eye umbrella? A review.
Autorzy:
Kantor NB; Bascom Palmer Eye Institute, University of Miami, Miami, Florida, USA.; Surgical Services, Miami Veterans Affairs Medical Center, Miami, Florida, USA.
Tovar A; Department of Ophthalmology, Wellstar MCG Health, Augusta, Georgia, USA.
Wang T; Division of Transplantation and Cellular Therapy, Sylvester Comprehensive Cancer Center, Adult Stem Cell Transplant Program, University of Miami Hospital and Clinics, Miami, Florida, USA.
Galor A; Bascom Palmer Eye Institute, University of Miami, Miami, Florida, USA.; Surgical Services, Miami Veterans Affairs Medical Center, Miami, Florida, USA.
Pokaż więcej
Źródło:
Clinical & experimental ophthalmology [Clin Exp Ophthalmol] 2024 Mar; Vol. 52 (2), pp. 167-185. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Dry Eye Syndromes*/diagnosis
Dry Eye Syndromes*/etiology
Graft vs Host Disease*/diagnosis
Graft vs Host Disease*/complications
Meibomian Gland Dysfunction*
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Cornea ; Conjunctiva
Czasopismo naukowe
Tytuł:
Impact of CD34 positive cell dose in donor graft on the outcomes after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide - A retrospective single-center study with a Japanese cohort.
Autorzy:
Maruyama Y; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan.
Nishikii H; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan; Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Kurita N; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan; Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Sakamoto T; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan; Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Hattori K; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan; Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Suehara Y; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan.
Yokoyama Y; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan; Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Kato T; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan; Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Obara N; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan; Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Sakata-Yanagimoto M; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan; Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan; Division of Advanced Hemato-Oncology, Transborder Medical Research Center, University of Tsukuba, Tsukuba, Japan.
Chiba S; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan; Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan. Electronic address: .
Pokaż więcej
Źródło:
Blood cells, molecules & diseases [Blood Cells Mol Dis] 2024 Mar; Vol. 105, pp. 102820. Date of Electronic Publication: 2023 Dec 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Peripheral Blood Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/adverse effects
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Humans ; Retrospective Studies ; Japan ; Cyclophosphamide/therapeutic use ; Transplantation Conditioning/adverse effects
Czasopismo naukowe
Tytuł:
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.
Autorzy:
Jullien M; Hematology Department, Nantes University Hospital, Nantes, France.; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.
Guillaume T; Hematology Department, Nantes University Hospital, Nantes, France.; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.
Le Bourgeois A; Hematology Department, Nantes University Hospital, Nantes, France.
Peterlin P; Hematology Department, Nantes University Hospital, Nantes, France.
Garnier A; Hematology Department, Nantes University Hospital, Nantes, France.
Eveillard M; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.; Hematology Biology, Nantes University Hospital, Nantes, France.
Le Bris Y; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.; Hematology Biology, Nantes University Hospital, Nantes, France.
Bouzy S; Hematology Biology, Nantes University Hospital, Nantes, France.
Tessoulin B; Hematology Department, Nantes University Hospital, Nantes, France.
Gastinne T; Hematology Department, Nantes University Hospital, Nantes, France.
Dubruille V; Hematology Department, Nantes University Hospital, Nantes, France.
Touzeau C; Hematology Department, Nantes University Hospital, Nantes, France.
Mahé B; Hematology Department, Nantes University Hospital, Nantes, France.
Blin N; Hematology Department, Nantes University Hospital, Nantes, France.
Lok A; Hematology Department, Nantes University Hospital, Nantes, France.
Vantyghem S; Hematology Department, Nantes University Hospital, Nantes, France.
Sortais C; Hematology Department, Nantes University Hospital, Nantes, France.
Antier C; Hematology Department, Nantes University Hospital, Nantes, France.
Moreau P; Hematology Department, Nantes University Hospital, Nantes, France.
Scotet E; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.
Béné MC; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.; Hematology Biology, Nantes University Hospital, Nantes, France.
Chevallier P; Hematology Department, Nantes University Hospital, Nantes, France.; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.
Pokaż więcej
Źródło:
American journal of hematology [Am J Hematol] 2024 Mar; Vol. 99 (3), pp. 350-359. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Clinical Trial, Phase I; Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/methods
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Graft vs Host Disease*/drug therapy
Humans ; Interleukin-2 ; Zoledronic Acid ; T-Lymphocytes/pathology ; Cyclophosphamide/therapeutic use ; Stem Cell Transplantation
Czasopismo naukowe
Tytuł:
Late-onset Pneumocystis jirovecii pneumonia post-allogeneic stem cell transplantation after time-dependent discontinuation of prophylaxis.
Autorzy:
Stavi V; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Allogeneic Transplant Unit, Soroka University Medical Centre, Beersheba, Israel.
Desai N; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Michelis FV; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Kim DDH; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Kumar R; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Lipton JH; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Law AD; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2024 Mar; Vol. 112 (3), pp. 433-438. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Pneumonia, Pneumocystis*/diagnosis
Pneumonia, Pneumocystis*/etiology
Pneumonia, Pneumocystis*/prevention & control
Pneumocystis carinii*
Graft vs Host Disease*/diagnosis
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Antilymphocyte Serum/therapeutic use ; Stem Cell Transplantation/adverse effects ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Clinical characteristics and outcomes of Epstein-Barr virus viral load after allogeneic hematopoietic stem cell transplantation.
Autorzy:
Tsushima T; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan. .
Masuda SI; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Yoda N; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Kainuma S; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Kimeda C; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Konno S; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Tanaka K; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Matsuo K; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Shimoji S; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Kimura K; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Arai H; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Utsu Y; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Imadome KI; Department of Advanced Medicine for Virus Infections, National Center for Child Health and Development (NCCHD), Tokyo, Japan.
Aotsuka N; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2024 Mar; Vol. 103 (3), pp. 935-946. Date of Electronic Publication: 2023 Dec 29.
Typ publikacji:
Journal Article
MeSH Terms:
Epstein-Barr Virus Infections*/drug therapy
Hematopoietic Stem Cell Transplantation*/adverse effects
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Graft vs Host Disease*/drug therapy
Lymphoproliferative Disorders*/etiology
Humans ; Herpesvirus 4, Human/physiology ; Retrospective Studies ; Viral Load ; Immunosuppressive Agents/therapeutic use ; DNA, Viral
Czasopismo naukowe
Tytuł:
Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia.
Autorzy:
Oved JH; Division of Pediatric Transplantation & Cellular Therapies, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Gibson NM; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.; Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Venella K; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Elgarten CW; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Wray L; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Warren JT; Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Olson TS; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 26; Vol. 15, pp. 1369243. Date of Electronic Publication: 2024 Feb 26 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Neutropenia*/*congenital
Hematopoietic Stem Cell Transplantation*/methods
Neutropenia*/complications
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Humans ; Child ; Bone Marrow Transplantation/adverse effects ; Congenital Bone Marrow Failure Syndromes ; Busulfan/therapeutic use ; Busulfan/pharmacology ; Siblings ; Prospective Studies ; Cyclophosphamide/therapeutic use ; Granulocyte Colony-Stimulating Factor/therapeutic use
SCR Disease Name:
Neutropenia, Severe Congenital, Autosomal Recessive 3
Czasopismo naukowe
Tytuł:
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial.
Autorzy:
Brissot E; Sorbonne Université, AP-HP, INSERM UMRs938, Paris, France ; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France. .
Labopin M; Sorbonne Université, AP-HP, INSERM UMRs938, Paris, France ; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.; European Society for Blood and Marrow Transplantation Paris Study Office/CEREST-TC, Paris, France.
Labussière H; Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
Fossard G; Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
Chevallier P; Hematology Department, Center Hospitalier Universitaire de Nantes, Nantes, France.
Guillaume T; Hematology Department, Center Hospitalier Universitaire de Nantes, Nantes, France.
Yakoub-Agha I; CHU Lille, Department of Hematology, Univ. Lille, INSERM U1286, Infinite, F-59000, Lille, France.
Srour M; CHU Lille, Department of Hematology, Univ. Lille, INSERM U1286, Infinite, F-59000, Lille, France.
Bulabois CE; Department of Hematology, CHU de Grenoble, Grenoble, France.
Huynh A; CHU-Institut Universitaire du Cancer Toulouse Oncopole (IUCT-O), Toulouse, France.
Chantepie S; Service d'Hématologie, Institut d'Hématologie de Basse-Normandie CHU de Caen, Caen, France.
Menard AL; Department of Hematology, Center Henri Becquerel, Rouen, France.
Rubio MT; University Hospital of Nancy, Vandoeuvre-Les-Nancy, France.
Ceballos P; Hematology Department, Saint-Eloi University Hospital, Montpellier, France.
Dulery R; Sorbonne Université, AP-HP, INSERM UMRs938, Paris, France ; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.
Furst S; Transplant and cellular immunotherapy program, Department of hematology, Institut Paoli Calmettes, Cancer research center of Marseille (CRCM), Aix-Marseille University (AMU), Marseille, France.
Malard F; Sorbonne Université, AP-HP, INSERM UMRs938, Paris, France ; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.
Blaise D; Transplant and cellular immunotherapy program, Department of hematology, Institut Paoli Calmettes, Cancer research center of Marseille (CRCM), Aix-Marseille University (AMU), Marseille, France.
Mohty M; Sorbonne Université, AP-HP, INSERM UMRs938, Paris, France ; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.
Pokaż więcej
Źródło:
Blood cancer journal [Blood Cancer J] 2024 Feb 19; Vol. 14 (1), pp. 31. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Humans ; Antilymphocyte Serum/therapeutic use ; Unrelated Donors ; Siblings ; Quality of Life ; Cyclophosphamide/therapeutic use ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants.
Autorzy:
Iacobescu M; Department of Proteomics and Metabolomics, MEDFUTURE Research Center for Advanced Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Pop C; Department of Pharmacology, Physiology and Pathophysiology, Faculty of Pharmacy, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Uifălean A; Department of Pharmaceutical Analysis, Faculty of Pharmacy, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Mogoşan C; Department of Pharmacology, Physiology and Pathophysiology, Faculty of Pharmacy, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Cenariu D; Department of Translational Medicine, MEDFUTURE Research Center for Advanced Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Zdrenghea M; Department of Hematology, Faculty of Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Tănase A; Department of Stem Cell Transplantation, Fundeni Clinical Institute, Bucharest, Romania.
Bergthorsson JT; Department of Laboratory Hematology, Stem Cell Research Unit, Biomedical Center, School of Health Sciences, University Iceland, Reykjavik, Iceland.
Greiff V; Department of Immunology, University of Oslo, Oslo, Norway.
Cenariu M; Department of Animal Reproduction, University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Romania.
Iuga CA; Department of Proteomics and Metabolomics, MEDFUTURE Research Center for Advanced Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Pharmaceutical Analysis, Faculty of Pharmacy, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Tomuleasa C; Department of Translational Medicine, MEDFUTURE Research Center for Advanced Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Hematology, Faculty of Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Tătaru D; Department of Internal Medicine, Faculty of Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 16; Vol. 15, pp. 1327035. Date of Electronic Publication: 2024 Feb 16 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Graft vs Host Disease*/diagnosis
Graft vs Host Disease*/etiology
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Biomarkers ; Conditioning, Psychological ; Proteomics
Czasopismo naukowe
Tytuł:
Janus kinase inhibition in the treatment and prevention of graft-versus-host disease.
Autorzy:
De Togni E; Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
Cole O; Division of Oncology, Washington University School of Medicine, St. Louis, MO, United States.
Abboud R; Division of Oncology, Washington University School of Medicine, St. Louis, MO, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 06; Vol. 15, pp. 1304065. Date of Electronic Publication: 2024 Feb 06 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Graft vs Host Disease*/drug therapy
Graft vs Host Disease*/prevention & control
Graft vs Host Disease*/etiology
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Janus Kinases ; Adrenal Cortex Hormones/therapeutic use ; Transplantation, Homologous/adverse effects
Czasopismo naukowe
Tytuł:
Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice.
Autorzy:
Cuthbertson P; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.
Button A; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.
Sligar C; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.
Elhage A; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.
Vine KL; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.
Watson D; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.
Sluyter R; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.; Illawarra Health and Medical Research Institute, Wollongong, NSW 2522, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 01; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Graft vs Host Disease*/drug therapy
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*/methods
Leukemia*/drug therapy
Rosaniline Dyes*
Humans ; Animals ; Mice ; Leukocytes, Mononuclear ; Mice, Inbred NOD ; Neoplasm Recurrence, Local/drug therapy ; Cyclophosphamide/therapeutic use ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Comparing between HLA-matched sibling donor allogenic HSCT and non-sibling matched related donor allogenic HSCT outcome in pediatric patients; single center retrospective study.
Autorzy:
Essa MF; Department of Pediatric Hematology/Oncology, King Abdullah Specialist Children's Hospital, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, National Guard Health Affairs, Riyadh, Saudi Arabia.
Alghazwani S; Department of Pediatric Hematology/Oncology, King Abdullah Specialist Children's Hospital, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Abujoub R; Department of Pediatric Hematology/Oncology, King Abdullah Specialist Children's Hospital, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Memon S; Department of Pediatric Hematology/Oncology, King Abdullah Specialist Children's Hospital, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Alkaiyat M; Department of Oncology, King Abdullah Specialist Children's Hospital, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Ardah H; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, National Guard Health Affairs, Riyadh, Saudi Arabia.
Alsultan A; Oncology Center, King Saud University Medical City, Riyadh, Saudi Arabia.
Pokaż więcej
Źródło:
Pediatric transplantation [Pediatr Transplant] 2024 Feb; Vol. 28 (1), pp. e14692.
Typ publikacji:
Journal Article
MeSH Terms:
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Child ; Retrospective Studies ; Transplantation, Homologous/methods ; Tissue Donors ; Siblings
Czasopismo naukowe
Tytuł:
Improvement of survival after hematopoietic stem cell transplantation and trends at a pediatric transplantation center; a three-decade journey.
Autorzy:
Sezgin G; Division of Pediatric Oncology & Pediatric BMT Unit, Çukurova University Medical School, Adana, Turkey.
Öner YS; Department of Pediatrics, Çukurova University Medical School, Adana, Turkey.
İnan G; Division of Pediatric Oncology & Pediatric BMT Unit, Çukurova University Medical School, Adana, Turkey.
Ünal İ; Department of Biostatistics, Çukurova University Medical School, Adana, Turkey.
Özkan A; Division of Pediatric Oncology & Pediatric BMT Unit, Çukurova University Medical School, Adana, Turkey.
Küpeli S; Division of Pediatric Oncology & Pediatric BMT Unit, Çukurova University Medical School, Adana, Turkey.
Bayram İ; Division of Pediatric Oncology & Pediatric BMT Unit, Çukurova University Medical School, Adana, Turkey.
Tanyeli A; Division of Pediatric Oncology & Pediatric BMT Unit, Çukurova University Medical School, Adana, Turkey.
Pokaż więcej
Źródło:
Pediatric transplantation [Pediatr Transplant] 2024 Feb; Vol. 28 (1), pp. e14691.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Graft vs Host Disease*/epidemiology
Graft vs Host Disease*/etiology
Humans ; Child ; Retrospective Studies ; Transplantation, Homologous/adverse effects ; Recurrence
Czasopismo naukowe
Tytuł:
Human MAIT cells inhibit alloreactive T cell responses and protect against acute graft-versus-host disease.
Autorzy:
Talvard-Balland N; INSERM UMR-976 HIPI, Saint Louis Research Institute, Université Paris Cité, Paris, France.
Lambert M; INSERM UMR-976 HIPI, Saint Louis Research Institute, Université Paris Cité, Paris, France.
Chevalier MF; INSERM UMR-976 HIPI, Saint Louis Research Institute, Université Paris Cité, Paris, France.
Minet N; INSERM UMR-976 HIPI, Saint Louis Research Institute, Université Paris Cité, Paris, France.
Salou M; Institut Curie, Université PSL, INSERM U932, Immunity and Cancer, Paris, France.
Tourret M; INSERM UMR-976 HIPI, Saint Louis Research Institute, Université Paris Cité, Paris, France.
Bohineust A; INSERM UMR-976 HIPI, Saint Louis Research Institute, Université Paris Cité, Paris, France.
Milo I; INSERM UMR-976 HIPI, Saint Louis Research Institute, Université Paris Cité, Paris, France.
Parietti V; Université Paris Cité, INSERM, CNRS, UMS Saint-Louis (US53/UAR2030), Paris, France.
Yvorra T; Institut Curie, Université PSL, CNRS UMR3666, INSERM U1143, Paris, France.
Socié G; INSERM UMR-976 HIPI, Saint Louis Research Institute, Université Paris Cité, Paris, France.; Hematology Transplantation, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.
Lantz O; Institut Curie, Université PSL, INSERM U932, Immunity and Cancer, Paris, France.; Clinical Immunology Laboratory, Institut Curie, Paris, France.; Centre d'investigation Clinique en Biothérapie Gustave-Roussy Institut Curie (CIC-BT1428), Paris, France.
Caillat-Zucman S; INSERM UMR-976 HIPI, Saint Louis Research Institute, Université Paris Cité, Paris, France.; Immunology Laboratory, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.
Pokaż więcej
Źródło:
JCI insight [JCI Insight] 2024 Feb 01; Vol. 9 (5). Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Mucosal-Associated Invariant T Cells*
Graft vs Host Disease*/prevention & control
Graft vs Host Disease*/etiology
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Mice ; Animals ; Leukocytes, Mononuclear ; Receptors, Antigen, T-Cell
Czasopismo naukowe
Tytuł:
Altered lipid metabolism in patients with acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Autorzy:
Tyszka M; Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland. Electronic address: .
Maciejewska-Markiewicz D; Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, 71-460 Szczecin, Poland.
Styburski D; Sanprobi Sp. Z O. O. Sp. K., Kurza Stopka 5/C, 70-535 Szczecin, Poland.
Biliński J; Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland.
Tomaszewska A; Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland.
Stachowska E; Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, 71-460 Szczecin, Poland.
Basak GW; Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland.
Pokaż więcej
Źródło:
Leukemia research [Leuk Res] 2024 Feb; Vol. 137, pp. 107435. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/methods
Humans ; Lipid Metabolism ; Prospective Studies ; Bile Acids and Salts ; Cholesterol ; Acute Disease
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies